Jonathan I Lieber insider trades
Open-market stock purchases and sales by Jonathan I Lieber, Chief Financial Officer at Rallybio Corp, from SEC Form 4 filings since Feb 28, 2013.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +215%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 9, 2026 | RLYB Rallybio Corp | Bought (not open market) | $23.8K |
| Oct 9, 2026 | RLYB Rallybio Corp | Bought (not open market) | — |
| Sep 29, 2026 | RLYB Rallybio Corp | Bought (not open market) | $30.4K |
| Sep 29, 2026 | RLYB Rallybio Corp | Bought (not open market) | — |
| Aug 31, 2026 | DCOY Decoy Therapeutics Inc | Bought (not open market) | — |
| Feb 23, 2026 | RLYB Rallybio Corp | Sold | $4K |
| Feb 18, 2026 | RLYB Rallybio Corp | Bought (not open market) | — |
Companies traded
- RLYB Rallybio Corp: 1 buy, 1 sale, last Oct 9, 2026
- DCOY Decoy Therapeutics Inc: other filings, last Aug 31, 2026
- SLRX Salarius Pharmaceuticals, Inc: 1 buy, last Feb 20, 2024
- AGTC Applied Genetic Technologies Corp: other filings, last Nov 30, 2022
- HSGX Histogenics Corp: 1 buy, last Oct 1, 2018
- RGEN Repligen Corp: other filings, last Feb 28, 2013